BioSpace News Archive

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical stage biotechnology company focused on the development of novel therapeutics for the treatment of rare diseases, today announced it will present clinical data on its lead product candidate, mavorixafor (X4P-001), in combination with Inlyta® (axitinib) at the upcoming European Society for Medical Oncology (ESMO) 2019 Congress, taking place September 27 – October 1 in Barcelona, Spain.

Faster, Simpler, Better: Dramatically Reduce Timelines, Simplify Study Start up, and Increase Quality in Hundreds of Clinical Trials Each Year

Nationwide campaign will take place in October

Preliminary findings enabled EpigenCare to develop a statistical model for approximating the age of an individual’s skin, irrespective of his or her chronological age.

Transformations has more than a dozen locations in the U.S. and is rapidly growing.

TRC’s offer is subject to a number of conditions, including TRC’s ability to obtain sufficient financing.

Medical Marijuana, Inc. (OTC: MJNA) (“the Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its major investment company AXIM® Biotechnologies, Inc. (“AXIM® Biotech” or “AXIM”) (OTCQB: AXIM) has begun manufacturing its cannabinoid-based chewing gum with dronabinol, a synthetic form of tetrahydrocannabinol (THC).

Catalia Health and Pfizer today announced they have launched a pilot program to explore patient behaviors outside of clinical environments and to test the impact regular engagement with artificial intelligence (AI) has on patients’ treatment journeys.

The Heart Failure Society of America (HFSA), a professional society of clinicians, researchers, and patients focused on reducing the burden of heart failure, has announced that basketball great Shaquille O’Neal will be a keynote speaker at the 23rd HFSA Annual Scientific Meeting.

Healthcare Finance business served as sole lead arranger for a $27.2 million loan for two assisted living facilities in Texas.